Genvax Technologies Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$3.4M
- Investors
-
9
Genvax Technologies General Information
Description
Developer of animal vaccines designed to accelerate treatments for the animal health industry. The company's saRNA platform allows for the rapid development of herd or flock-specific vaccines matched to the variant strain circulating in an animal-production operation by inserting a specific transgene or gene of interest matched to the variant strain into the platform, the saRNA can generate an antibody response without requiring the whole pathogen, enabling clients with novel vaccines for the prevention and treatment of animal diseases.
Contact Information
Website
www.genvax.comCorporate Office
- 2503 South Loop Drive
- Suite 5446
- Ames, IA 50010
- United States
Corporate Office
- 2503 South Loop Drive
- Suite 5446
- Ames, IA 50010
- United States
Genvax Technologies Timeline
Genvax Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 24-Jun-2024 | $3.4M | Completed | Clinical Trials - General | ||
| 2. Seed Round | 09-Aug-2022 | Completed | Clinical Trials - General | |||
| 1. Grant | 18-Apr-2022 | $145K | Completed | Clinical Trials - General |
Genvax Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Genvax Technologies Executive Team (2)
| Name | Title | Board Seat |
|---|---|---|
| Hank Harris Ph.D | Co-Founder & Board Member | |
| Joel Harris | Co-Founder, Chief Executive Officer & Board Member |
Genvax Technologies Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Hank Harris Ph.D | Genvax Technologies | Co-Founder & Board Member | |
| Joel Harris | Self | Co-Founder, Chief Executive Officer & Board Member | |
| Scott Holmstrom Ph.D | Self | Board Member | |
| Trent Torrance | United Animal Health | Board Member |
Genvax Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Genvax Technologies Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 1945 Capital | Family Office | Minority | ||
| Grit Road Partners | Venture Capital | Minority | ||
| Ag Startup Engine | Venture Capital | Minority | ||
| Ag Ventures Alliance | Venture Capital | Minority | ||
| Iowa Corn Opportunities | Venture Capital | Minority |
Genvax Technologies FAQs
-
When was Genvax Technologies founded?
Genvax Technologies was founded in 2021.
-
Who is the founder of Genvax Technologies?
Hank Harris Ph.D and Joel Harris are the founders of Genvax Technologies.
-
Who is the CEO of Genvax Technologies?
Joel Harris is the CEO of Genvax Technologies.
-
Where is Genvax Technologies headquartered?
Genvax Technologies is headquartered in Ames, IA.
-
What is the size of Genvax Technologies?
Genvax Technologies has 10 total employees.
-
What industry is Genvax Technologies in?
Genvax Technologies’s primary industry is Other Commercial Products.
-
Is Genvax Technologies a private or public company?
Genvax Technologies is a Private company.
-
What is Genvax Technologies’s current revenue?
The current revenue for Genvax Technologies is .
-
How much funding has Genvax Technologies raised over time?
Genvax Technologies has raised $11.8M.
-
Who are Genvax Technologies’s investors?
1945 Capital, Grit Road Partners, Ag Startup Engine, Ag Ventures Alliance, and Iowa Corn Opportunities are 5 of 9 investors who have invested in Genvax Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
